PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
1.02
0.12 (13.35%)
At close: Aug 18, 2025, 3:59 PM
1.02
0.00%
Pre-market: Aug 19, 2025, 07:00 AM EDT
PharmaCyte Biotech Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.04M | -960K | -1.11M | -1.27M | -3.17M | -1.87M | -1.41M | -2.08M | -903K | -1.55M | -2.32M | -1.68M | -1.51M | -856K | -1M | -1.02M | -1.03M | -757K | -950K | -882K |
Interest Income | 229.88K | 255.69K | 382.56K | 547.43K | 747.1K | 881.66K | 894.18K | 875.88K | 722.94K | 635.89K | 439.17K | 139.5K | 86.57K | 45.46K | 25.62K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 11.75M | -3.04M | -1.47M | 23.42M | 1.35M | -620K | 2.79M | -3.18M | -126K | -764K | -1.88M | -1.54M | -1.42M | -811K | -980K | -1.02M | -960K | -757K | -950K | -884K |
Net Income | 11.75M | -3.04M | -1.47M | 23.42M | 1.35M | -620K | 2.79M | -3.18M | -126K | 24.71K | -1.44M | -1.54M | -1.42M | -766K | -980K | -1.02M | -960K | -757K | -950K | -884K |
Selling & General & Admin | 1.82M | 842.06K | 1.01M | 1.17M | 1.07M | 1.74M | 1.33M | 1.97M | 817.41K | 1.51M | 2.14M | 1.52M | 1.25M | 698.08K | 869.62K | 879.74K | 714.67K | 582.76K | 798.2K | 611.1K |
Research & Development | 126.73K | 118.2K | 97.47K | 96.02K | 94.18K | 126.73K | 82.03K | 104.48K | 85.87K | 45.39K | 178K | 159.27K | 254.06K | 158.04K | 135.22K | 143.61K | 320.27K | 174.09K | 151.31K | 270.57K |
Other Expenses | -905.68K | n/a | -859 | 113.00 | 2M | 54.00 | 480.00 | -1.85K | n/a | n/a | -1.06K | -3.91K | -1.57K | -630 | -480 | -1.6K | n/a | n/a | n/a | -1.88K |
Operating Expenses | 1.04M | 960.25K | 1.11M | 1.27M | 3.17M | 1.87M | 1.41M | 2.08M | 903.28K | 1.55M | 2.32M | 1.68M | 1.51M | 856.12K | 1M | 1.02M | 1.03M | 756.85K | 949.51K | 881.68K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.00 | 467.00 | 1.04K | 249.00 | 677.00 | 388.00 |
Selling & Marketing Expenses | n/a | 232.86K | 283.33K | 389.48K | 232.48K | 620.78K | 229.16K | 240K | 255.26K | 251.56K | 400.42K | 327.72K | 743.74K | 267.11K | 265.01K | 268.88K | 261.62K | 336.1K | 552.46K | 278.97K |
Cost & Expenses | 1.04M | 960.25K | 1.11M | 1.27M | 3.17M | 1.87M | 1.41M | 2.08M | 903.28K | 1.55M | 2.32M | 1.68M | 1.51M | 856.12K | 1M | 1.02M | 1.03M | 756.85K | 949.51K | 881.68K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -1.87K | n/a | n/a | n/a | -789K | -438K | n/a | n/a | -44.83K | n/a | 467.00 | 1.04K | -756 | -949 | 388.00 |
Shares Outstanding (Basic) | 6.8M | 6.96M | 7.64M | 7.87M | 8.04M | 8.61M | 10.83M | 12.6M | 16.79M | 19M | 20.59M | 20.83M | 15.52M | 21.67M | 17.36M | 1.59M | 1.56M | 1.56M | 1.54M | 1.12M |
Shares Outstanding (Diluted) | 6.8M | 6.96M | 7.64M | 7.87M | 8.35M | 8.61M | 8.77M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 1.59M | 1.56M | 1.56M | 1.54M | 1.12M |
EPS (Basic) | 1.60 | -0.44 | -0.39 | 1.90 | -0.32 | -0.65 | -0.26 | -0.54 | -0.01 | 0.00 | -0.09 | -0.07 | -0.08 | -0.04 | -0.06 | -0.64 | -0.62 | -0.49 | -0.62 | -0.79 |
EPS (Diluted) | 1.60 | -0.44 | -0.39 | 1.90 | -0.3 | -0.65 | -0.26 | -0.61 | -0.02 | 0.00 | -0.28 | -0.3 | -0.27 | -0.15 | -0.19 | -0.64 | -0.62 | -0.49 | -0.62 | -0.79 |
EBITDA | -1.04M | -960K | -1.11M | -1.27M | 1.35M | -1.87M | -1.41M | -2.08M | -126K | -764K | -1.88M | -1.54M | -1.49M | -811K | -980K | -1.02M | -959K | -757K | -950K | -884K |
EBIT | -1.04M | -960K | -1.47M | -1.27M | -1.17M | -1.87M | -1.41M | -2.08M | -903K | -1.55M | -2.32M | -1.68M | -1.42M | -811K | -980K | -1.02M | -959K | -757K | -950K | -884K |
Depreciation & Amortization | n/a | 960.25K | 1.11M | 1.27M | 3.03M | 1.87K | 1.41M | 2.08M | 903.28K | 1.55M | 2.32M | 1.68M | -69.97K | 856.12K | 1M | 1.02M | 1.03M | 756.85K | 949.51K | 881.68K |